Results 51 to 60 of about 590,194 (288)

The cost-effectiveness of alternative vaccination strategies for polyvalent meningococcal vaccines in Burkina Faso: A transmission dynamic modeling study. [PDF]

open access: yesPLoS Medicine, 2018
BACKGROUND:The introduction of a conjugate vaccine for serogroup A Neisseria meningitidis has dramatically reduced disease in the African meningitis belt.
Reza Yaesoubi   +8 more
doaj   +1 more source

An increase in accident and emergency presentations for adverse events following immunisation after introduction of the group B meningococcal vaccine: an observational study

open access: yesArchives of Disease in Childhood, 2017
Objectives To determine whether the introduction of the capsular group B meningococcal vaccine (4CMenB) in the UK has increased presentations of infants to emergency departments with adverse events following immunisation (AEFI).
Viveka Nainani   +3 more
semanticscholar   +1 more source

Incidence of Meningococcal Disease Before and After Implementation of Quadrivalent Meningococcal Conjugate Vaccine in the United States.

open access: yesJAMA pediatrics, 2020
Importance In 2005, the US Advisory Committee on Immunization Practices recommended routine quadrivalent meningococcal conjugate (MenACWY) vaccine for all adolescents aged 11 to 12 years, and in 2010, a booster dose for adolescents aged 16 years ...
Sarah A Mbaeyi   +8 more
semanticscholar   +1 more source

Construction of Opa-positive and Opa-negative strains of Neisseria meningitidis to evaluate a novel meningococcal vaccine. [PDF]

open access: yesPLoS ONE, 2012
Neisseria meningitidis is a major global pathogen causing invasive disease with a mortality of 5-10%. Most disease in developed countries is caused by serogroup B infection, against which there is no universal vaccine.
Manish Sadarangani   +11 more
doaj   +1 more source

Safety and Immunogenicity of Meningococcal Groups A and C Polysaccharide Vaccine in Adults 18–60 years of age

open access: yesЭпидемиология и вакцинопрофилактика, 2023
Relevance. In the Russian Federation, despite the low incidence rate in 2020–2021, there are subjects where the incidence rate of meningococcal infection (MI) exceeds the national average by 2–9 times.
V. V. Romanenko   +3 more
doaj   +1 more source

The Impact of Vaccination Behavior on Disease Spreading Based on Complex Networks [PDF]

open access: yesarXiv, 2021
Vaccination is an effective way to prevent and control the occurrence and epidemic of infectious diseases. However, many factors influence whether the residents decide to get vaccinated or not, such as the efficacy and side effects while individuals hope to obtain immunity through vaccination.
arxiv  

Safety and immunogenicity of co-administration of meningococcal type A and measles–rubella vaccines with typhoid conjugate vaccine in children aged 15–23 months in Burkina Faso

open access: yesInternational Journal of Infectious Diseases, 2020
Highlights • This is the first study on the co-administration of typhoid conjugate vaccine (TCV) in West Africa.• Co-administration of TCV with routine vaccines in a typhoid-endemic country was successful.• TCV was safely co-administered at 15 months ...
S. Sirima   +18 more
semanticscholar   +1 more source

COVID-19 Vaccine Hesitancy and Information Diffusion: An Agent-based Modeling Approach [PDF]

open access: yesarXiv, 2021
Despite the unprecedented success in the rapid development of several effective vaccines against the Cov-SARS-2, global vaccination rollout efforts suffer from vaccine distribution inequality and vaccine acceptance, leading to insufficient public immunity provided by the vaccine products.
arxiv  

Impact of vaccination on meningococcal epidemiology [PDF]

open access: yesHuman Vaccines & Immunotherapeutics, 2015
Neisseria meningitidis may cause invasive disease (meningitis and sepsis), leading to considerable disease burden and mortality. However, effective vaccines are available against most pathogenic serogroups. Large-scale vaccination campaigns with the MCC vaccine conducted in UK and with MenAfriVac in the Sahel have clearly demonstrated the direct and ...
Stefanelli P, Rezza G
openaire   +3 more sources

Immunogenicity and safety of a booster dose of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in adolescents and adults: a Phase III randomized study

open access: yesHuman Vaccines & Immunotherapeutics, 2020
The quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) was assessed as a booster in this Phase III trial (NCT02752906). Quadrivalent meningococcal conjugate vaccine (MCV4)-primed individuals aged ≥15 y (n = 810) were randomized 1:1 ...
G. Áñez   +8 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy